Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: A randomized controlled trial

Obstetrics and Gynecology

Volumn 119, Issue 6, 2012, Pages 1143-1150

  Dmitrovic, Romana ^a,b   Kunselman, Allen R ^a,b   Legro, Richard S ^a,b  

^a BetaPlus Center for Reproductive Medicine   (Croatia)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; GESTODENE;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSMENORRHEA; FEMALE; HUMAN; INTERMETHOD COMPARISON; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WEIGHT GAIN;

ADOLESCENT; ADULT; BLOOD PRESSURE; BODY WEIGHT; CONTRACEPTIVES, ORAL; DRUG THERAPY, COMBINATION; DYSMENORRHEA; ETHINYL ESTRADIOL; FEMALE; HUMANS; NORPREGNENES; PAIN; PAIN MEASUREMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861606404     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318257217a     Document Type: Article

References (30)

1. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 1982;144;: 655-60.
2. Dawood MY. Ibuprofen and dysmenorrhea. Am J Med 1984; 77:87-94.
3. Hauksson A, Akerlund M, Melin P. Uterine blood flow and myometrial activity at menstruation, and the action of vasopressin and a synthetic antagonist. Br J Obstet Gynaecol 1988;95:898-904.
4. Pulkkinen MO. Prostaglandins and the non-pregnant uterus. The pathophysiology of primary dysmenorrhea. Acta Obstet Gynecol Scand Suppl 1983;113:63-7.
5. Akerlund M.Vascularization of human endometrium. Uterine blood flow in healthy condition and in primary dysmenorrhoea. Ann N Y Acad Sci 1994;734:47-56.
6. Wong CL, Farquhar C, Roberts H, Proctor M. Oral contraceptive pill for primary dysmenorrhoea. The Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD002120. DOI: 10.1002/14651858.CD002120.pub3.
7. Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives. Drugs 2004;64:2447-62.
8. Vercellini P, De Giorgi O, Mosconi P, Stellato G, Vicentini S, Crosignani PG. Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril 2002;77:52-61.
9. Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasin R, Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003;80: 560-3.
10. Littman GS, Walker BR, Schneider BE. Reassessment of verbal and visual analog ratings in analgesic studies. Clin Pharmacol Ther 1985;38:16-23.
11. Markum RA. Assessment of the reliability of and the effect of neutral instructions on the symptom ratings on the Moos Menstrual Distress Questionnaire. Psychosom Med 1976;38: 163-72.
12. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
13. Littell RC, Stroup WW, Wolfinger RD, Schabenberger O. SAS for mixed models. 2nd edition. Cary (NC): SAS Institute Inc; 2006.
14. Hilbe J. Negative binomial regression. Cambridge (UK): Cambridge University Press; 2007.
15. Davis AR, Westhoff C, O'Connell K, Gallagher N. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. Obstet Gynecol 2005;106:97-104.
16. Kwiecien M, Edelman A, Nichols MD, Jensen JT. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception 2003;67:9-13.
17. Thomas SL, Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet 2000;355:922-4.
18. Legro RS, Pauli JG, Kunselman AR, Meadows JW, Kesner JS, Zaino RJ, et al. Effects of continuous versus cyclical oral contraception: a randomized controlled trial. J Clin Endocrinol Metab 2008;93:420-9.
19. Kaunitz AM. Menstruation: choosing whether.and when. Contraception 2000;62:277-84.
20. Loudon NB, Foxwell M, Potts DM, Guild AL, Short RV. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen. BMJ 1977;2:487-90.
21. Hamerlynck JV, Vollebregt JA, Doornebos CM, Muntendam P. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives. Contraception, 1987; 35:199-205.
22. Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 2003;68: 89-96.
23. Barbosa IC, Filho CI, Faggion D Jr, Baracat EC. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse). Contraception 2006;73:30-3.
24. Ross C, Coleman G, Stojanovska C. Prospectively reported symptom change across the menstrual cycle in users and non-users of oral contraceptives. J Psychosom Obstet Gynaecol 2003;24:15-29.
25. Gallo MF, Lopez LM, Grimes DA, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. The Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD003987. DOI: 10.1002/14651858.CD003987.pub4.
26. Boldo A, White WB. Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies. Endocrinol Metab Clin North Am 2011;40:419-32, ix.
27. Hickson SS, Miles KL, McDonnell BJ, Yasmin, Cockcroft JR, Wilkinson IB, et al. Use of the oral contraceptive pill is associated with increased large artery stiffness in young women: the ENIGMA study. J Hypertens 2011;29:1155-9.
28. Machado RB, Fabrini P, Cruz AM, Maia E, da Cunha Bastos A. Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 microg) and gestodene (75 microg). Contraception 2004;70:365-70.
29. Rabe T, Nitsche DC, Runnebaum B. The effects of monophasic and triphasic oral contraceptives on ovarian function and endometrial thickness. Eur J Contracept Reprod Health Care 1997;2:39-51.
30. Grow DR, Iromloo K. Oral contraceptives maintain a very thin endometrium before operative hysteroscopy. Fertil Steril 2006;85:204-7.